Terms: = Gastric cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Clinical Outcome
5 results:
1. Targeting PRSS23 with tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3/p38 MAPK-IL24 pathway.
Xiong JX; Li YT; Tan XY; Chen T; Liu BH; Fu L
Acta Pharmacol Sin; 2024 Feb; 45(2):405-421. PubMed ID: 37814123
[TBL] [Abstract] [Full Text] [Related]
2. Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum.
Appunni S; Rubens M; Ramamoorthy V; Anand V; Khandelwal M; Saxena A; McGranaghan P; Odia Y; Kotecha R; Sharma A
Clin Chim Acta; 2021 Mar; 514():1-7. PubMed ID: 33333043
[TBL] [Abstract] [Full Text] [Related]
3. RN181 is a tumour suppressor in gastric cancer by regulation of the erk/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma.
Guo W; Dong Z; Guo Y; Lin X; Chen Z; Kuang G; Yang Z
Clin Exp Metastasis; 2013 Mar; 30(3):265-75. PubMed ID: 22983529
[TBL] [Abstract] [Full Text] [Related]
5. Expression profiling and long lasting responses to chemotherapy in metastatic gastric cancer.
Lo Nigro C; Monteverde M; Riba M; Lattanzio L; Tonissi F; Garrone O; Heouaine A; Gallo F; Ceppi M; Borghi F; Comino A; Merlano M
Int J Oncol; 2010 Nov; 37(5):1219-28. PubMed ID: 20878069
[TBL] [Abstract] [Full Text] [Related]
